SK279522B6 - Farmaceutický prostriedok a jeho použitie - Google Patents

Farmaceutický prostriedok a jeho použitie Download PDF

Info

Publication number
SK279522B6
SK279522B6 SK45-96A SK4596A SK279522B6 SK 279522 B6 SK279522 B6 SK 279522B6 SK 4596 A SK4596 A SK 4596A SK 279522 B6 SK279522 B6 SK 279522B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
ribose
composition
animals
mice
Prior art date
Application number
SK45-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK4596A3 (en
Inventor
Olga Kufudaki
Original Assignee
Aliatros Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aliatros Medical filed Critical Aliatros Medical
Publication of SK4596A3 publication Critical patent/SK4596A3/sk
Publication of SK279522B6 publication Critical patent/SK279522B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK45-96A 1993-07-12 1994-07-12 Farmaceutický prostriedok a jeho použitie SK279522B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ931385A CZ281462B6 (cs) 1993-07-12 1993-07-12 Farmaceutický prostředek pro imunomodulační a adjuvantní léčbu
PCT/CZ1994/000015 WO1995002398A1 (en) 1993-07-12 1994-07-12 Pharmaceutical composition for immunomodulating and adjuvant treatment

Publications (2)

Publication Number Publication Date
SK4596A3 SK4596A3 (en) 1996-07-03
SK279522B6 true SK279522B6 (sk) 1998-12-02

Family

ID=5463211

Family Applications (1)

Application Number Title Priority Date Filing Date
SK45-96A SK279522B6 (sk) 1993-07-12 1994-07-12 Farmaceutický prostriedok a jeho použitie

Country Status (13)

Country Link
US (1) US5672590A (ja)
EP (1) EP0706388A1 (ja)
JP (1) JPH08512326A (ja)
CN (1) CN1128948A (ja)
AU (1) AU688435B2 (ja)
BR (1) BR9407197A (ja)
CA (1) CA2166774C (ja)
CZ (3) CZ281462B6 (ja)
HU (1) HUT77652A (ja)
NZ (1) NZ267968A (ja)
PL (1) PL176375B1 (ja)
SK (1) SK279522B6 (ja)
WO (1) WO1995002398A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US6071888A (en) * 1996-01-24 2000-06-06 Aliatros Medical, A.S. Composition for treating cancer
RS50101B (sr) * 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
EP0967984A1 (en) * 1997-03-04 2000-01-05 Peregrine Pharmaceutical, Inc. Composition and method for treating cancer and immunological disorders resulting in chronic conditions
SG85133A1 (en) * 1999-09-22 2001-12-19 Eliseo Garuti Alimentary integrator
DE102010045185A1 (de) * 2010-09-13 2012-03-15 Marianne Broendlund Stoffgemisch, Verwendung und Infusionslösung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110610A1 (de) * 1981-03-18 1982-10-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Chemokinesine und chemotaxine der leukozyten und des entzuendungsgewebes: natuerliche mediatoren zur selektiven reversiblen motilitaetsbeinflussung (chemokinesis) und chemische anlockung (chemotaxis) bei der ansammlung von leukozyten
JPH0625276A (ja) * 1992-05-13 1994-02-01 Tanabe Seiyaku Co Ltd アシルアミノ糖誘導体及びその製法

Also Published As

Publication number Publication date
US5672590A (en) 1997-09-30
CZ138593A3 (en) 1995-01-18
CA2166774C (en) 1999-11-30
CZ281462B6 (cs) 1996-10-16
BR9407197A (pt) 1996-09-17
AU1240295A (en) 1995-02-13
CN1128948A (zh) 1996-08-14
HU9600067D0 (en) 1996-03-28
PL312563A1 (en) 1996-04-29
CZ3000U1 (cs) 1995-02-22
WO1995002398A1 (en) 1995-01-26
AU688435B2 (en) 1998-03-12
CZ5191U1 (cs) 1996-09-12
JPH08512326A (ja) 1996-12-24
SK4596A3 (en) 1996-07-03
EP0706388A1 (en) 1996-04-17
NZ267968A (en) 1996-08-27
CA2166774A1 (en) 1995-01-26
PL176375B1 (pl) 1999-05-31
HUT77652A (hu) 1998-07-28

Similar Documents

Publication Publication Date Title
Schwartz et al. The effects of 6-mercaptopurine on homograft reactions
Carlisle Silicon: an essential element for the chick
Mayrhofer et al. Mast cells in severely T-cell depleted rats and the response to infestation with Nippostrongylus brasiliensis.
DE3519361A1 (de) (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
Phillips et al. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
Leung et al. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.
EP0170099B1 (de) Verwendung von Lycorin als Immunsuppressor
Chowdhury et al. Cadmium-induced immunopathology is prevented by zinc administration in mice
SK279522B6 (sk) Farmaceutický prostriedok a jeho použitie
Gottlieb et al. Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization
Rogers et al. Augmentation of murine natural killer cell activity by manganese chloride
Aminin et al. Radioprotective properties of cumaside, a complex of triterpene glycosides from the sea cucumber Cucumaria japonica and cholesterol
Gasic et al. Total suppression of pregnancy in mice by post-coital administration of neuraminidase
Lotzova et al. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
Kilpatrick et al. The immunosuppressive nature of tomato lectin and its possible clinical relevance
US20100303933A1 (en) Immunopotentiating composition from labisia pumila extract
Khan et al. Suppression of lymphocyte blastogenesis in man following cis-platinous diamminodichloride administration
Exon et al. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats
RU2473340C1 (ru) Способ получения препарата для стимуляции неспецифической резистентности и обмена веществ у животных
Jinquan et al. All roads lead to Rome: pathways of NKT cells promoting asthma
Diniz et al. Subacute toxicology studies on the aqueous fraction of the ethanol extract of the leaves of Cissampelos sympodialis Eichl.(Menispermaceae) in dogs
Mandi et al. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
WO2005058333A1 (de) Methode zur gewinnung eines biologisch aktiven mit elektroschock behandelten blutserums und seine verwendung
Schatz et al. Effect of D2O on Phytohemagglutinin-Induced Lymphocyte Proliferation
JPH11503426A (ja) 造血機能に関して刺激活性を示すmdp誘導体および複合体ならびにそれらを含む組成物